Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 2146 AL 2160

Clinical benefit of MAO-B and COMT inhibition in Parkinson's disease: practical considerations

Regensburger M, Ip CW, Kohl Z, Schrader C, Urban PP, Kassubek J, Jost WH.

J Neural Transm (Vienna). 2023 Jun;130(6):847-861. doi: 10.1007/s00702-023-02623-8. Epub 2023 Mar 24.

The Role of Telemedicine in the Treatment of Cognitive and Psychological Disorders in Parkinson's Disease: An Overview

Latella D, Maresca G, Formica C, Sorbera C, Bringandì A, Di Lorenzo G, Quartarone A, Marino S.

Brain Sci. 2023 Mar 16;13(3):499. doi: 10.3390/brainsci13030499.

PET Imaging of Neuro-Inflammation with Tracers Targeting the Translocator Protein (TSPO), a Systematic Review: From Bench to Bedside

Corica F, De Feo MS, Gorica J, Sidrak MMA, Conte M, Filippi L, Schillaci O, De Vincentis G, Frantellizzi V.

Diagnostics (Basel). 2023 Mar 8;13(6):1029. doi: 10.3390/diagnostics13061029.

Possible Signaling Pathways in the Gut Microbiota-Brain Axis for the Development of Parkinson's Disease Caused by Chronic Consumption of Food Additives

Martinez-Vega MV, Galván-Menéndez-Conde S, Freyre-Fonseca V.

ACS Chem Neurosci. 2023 Jun 7;14(11):1950-1962. doi: 10.1021/acschemneuro.3c00170. Epub 2023 May 12.

Targeting Sigma-1 Receptor: A Promising Strategy in the Treatment of Parkinson's Disease

Siddiqui T, Bhatt LK.

Neurochem Res. 2023 Oct;48(10):2925-2935. doi: 10.1007/s11064-023-03960-6. Epub 2023 May 31.

Microbiome-Gut-Brain Axis Modulation: New Approaches in Treatment of Parkinson's Disease and Amyotrophic Lateral Sclerosis

Kargbo RB.

ACS Med Chem Lett. 2023 Jun 9;14(7):886-888. doi: 10.1021/acsmedchemlett.3c00221. eCollection 2023 Jul 13.

Effect of Music Based Therapy Rhythmic Auditory Stimulation (RAS) Using Wearable Device in Rehabilitation of Neurological Patients: A Systematic Review

Scataglini S, Van Dyck Z, Declercq V, Van Cleemput G, Struyf N, Truijen S.

Sensors (Basel). 2023 Jun 26;23(13):5933. doi: 10.3390/s23135933.

The Pitfalls and Perspectives of Assessing Olfactory Function via Optical Brain Imaging

Akın Öztürk G, Ermiş G, Eskicioğlu E, Güdücü Ç.

Turk Arch Otorhinolaryngol. 2023 Mar;61(1):37-42. doi: 10.4274/tao.2023.2023-1-6. Epub 2023 Aug 11.

Impulse Control Disorders in Patients with Pituitary Tumors Treated with Dopamine Agonists: A Systematic Review

Hamblin R, Karavitaki N.

Arch Med Res. 2023 Dec;54(8):102910. doi: 10.1016/j.arcmed.2023.102910. Epub 2023 Nov 19.

Chronic pain relief after receiving affective touch: A single case report

Meijer LL, Ruis C, van der Smagt MJ, Dijkerman HC.

J Neuropsychol. 2023 Sep;17(3):584-589. doi: 10.1111/jnp.12321. Epub 2023 Apr 28.

Foslevodopa–foscarbidopa for treating advanced Parkinson’s with motor symptoms

London: National Institute for Health and Care Excellence (NICE); 2023 Nov 29.

Structural and Functional Imaging Correlates of Visual Hallucinations in Parkinson's Disease

Bhome R, Thomas GEC, Zarkali A, Weil RS.

Curr Neurol Neurosci Rep. 2023 Jun;23(6):287-299. doi: 10.1007/s11910-023-01267-1. Epub 2023 May 1.

Mitochondrial Complex I as a Pathologic and Therapeutic Target for Parkinson's Disease

Tryphena KP, Nikhil US, Pinjala P, Srivastava S, Singh SB, Khatri DK.

ACS Chem Neurosci. 2023 Mar 29. doi: 10.1021/acschemneuro.2c00819. Online ahead of print.

The Role of Cellular Defense Systems of Ferroptosis in Parkinson's Disease and Alzheimer's Disease

Chu J, Li J, Sun L, Wei J.

Int J Mol Sci. 2023 Sep 14;24(18):14108. doi: 10.3390/ijms241814108.

Parkinson's Disease: Exploring Different Animal Model Systems

Khan E, Hasan I, Haque ME.

Int J Mol Sci. 2023 May 22;24(10):9088. doi: 10.3390/ijms24109088.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias